Shimoyama Y, Sakamoto R, Akaboshi T, Tanaka M, Ohtsuki K
Laboratory of Genetical Biochemistry, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.
Biol Pharm Bull. 2001 Sep;24(9):1004-8. doi: 10.1248/bpb.24.1004.
By means of heparin-affinity and glycyrrhizin (GL)-affinity column chromatographies (HPLC), a GL-binding phospholipase A2 (gbPLA2) was selectively purified from the synovial fluids of patients with rheumatoid arthritis. This purified gbPLA2 was identified as a secretory type IIA PLA2 (sPLA2-IIA) since it was crossreacted with anti-sPLA2-IIA serum. The activity of purified sPLA2-IIA was inhibited by glycyrrhetinic acid (GA) and a GA derivative (oGA) in a dose-dependent manner, but it was more sensitive to GA than GL. Furthermore, it was found that (i) purified sPLA2-IIA is phosphorylated by casein kinase II (CK-II) in vitro; (ii) this phosphorylation induces in a significant stimulation of PLA2 activity; and (iii) oGA at one-tenth the concentration of GL inhibits the CK-II-mediated stimulation of sPLA2-IIA activity. These results show that (i) sPLA2-IIA is a GL-binding protein; and (ii) CK-II mediates stimulation of its PLA2 activity in vitro.
通过肝素亲和色谱法和甘草酸(GL)亲和柱色谱法(高效液相色谱法),从类风湿性关节炎患者的滑液中选择性纯化出一种GL结合型磷脂酶A2(gbPLA2)。这种纯化的gbPLA2被鉴定为分泌型IIA磷脂酶A2(sPLA2-IIA),因为它与抗sPLA2-IIA血清发生交叉反应。纯化的sPLA2-IIA的活性被甘草次酸(GA)和一种GA衍生物(oGA)以剂量依赖的方式抑制,但它对GA比对GL更敏感。此外,还发现:(i)纯化的sPLA2-IIA在体外被酪蛋白激酶II(CK-II)磷酸化;(ii)这种磷酸化导致PLA2活性显著增强;(iii)浓度为GL十分之一的oGA抑制CK-II介导的sPLA2-IIA活性增强。这些结果表明:(i)sPLA2-IIA是一种GL结合蛋白;(ii)CK-II在体外介导其PLA2活性的增强。